» Articles » PMID: 34909062

Pharmacological Basis for the Potential Role of Azithromycin and Doxycycline in Management of COVID-19

Overview
Journal Arab J Chem
Date 2021 Dec 15
PMID 34909062
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

A novel corona virus SARS-CoV-2 has led to an outbreak of the highly infectious pandemic COVID-19 complicated viral pneumonia. Patients with risk factors frequently develop secondary infections where the role of appropriate antibiotics is mandatory. However, the efforts of drug repurposing lead to recognizing the role of certain antibiotics beyond the management of infection. The current review provided the detailed antiviral, immunomodulatory effect, unique pharmacokinetic profile of two antibiotics namely azithromycin (AZ) and doxycycline (DOX). It summarizes current clinical trials and concerns regarding safety issues of these drugs. Azithromycin (AZ) has amazing lung tissue access, wide range antibacterial efficacy, conceivable antiviral action against COVID-19. It also showed efficacy when combined with other antiviral drugs in limited clinical trials, but many clinicians raise concerns regarding cardiovascular risk in susceptible patients. DOX has a considerable role in the management of pneumonia, it has some advantages including cardiac safety, very good access to lung tissue, potential antiviral, and immunomodulation impact by several mechanisms. The pharmacological profiles of both drugs are heightening considering these medications for further studies in the management of COVID-19.

Citing Articles

National trends in Azithromycin consumption during 2017-2023 in Kazakhstan: impact of the COVID-19 pandemic and the imperative for enhanced clinical guidelines.

Kassym L, Kussainova A, Semenov D, Aimurziyeva A, Uzbekova S, Semenova Y Sci Rep. 2025; 15(1):6309.

PMID: 39984711 PMC: 11845685. DOI: 10.1038/s41598-025-91216-4.


Repurposing existing drugs for the treatment ofCOVID-19/SARS-CoV-2: A review of pharmacological effects and mechanism of action.

Liang Y, Quan X, Gu R, Meng Z, Gan H, Wu Z Heliyon. 2024; 10(16):e35988.

PMID: 39247343 PMC: 11379597. DOI: 10.1016/j.heliyon.2024.e35988.


Doxycycline's Potential Role in Reducing Thrombosis and Mortality in Critically Ill Patients With COVID-19: A Multicenter Cohort Study.

Al Sulaiman K, Aljuhani O, Korayem G, Alnajjar L, Altebainawi A, AlFaifi M Clin Appl Thromb Hemost. 2023; 29:10760296231177017.

PMID: 37322869 PMC: 10278434. DOI: 10.1177/10760296231177017.


Immunomodulatory role of azithromycin: Potential applications to radiation-induced lung injury.

Yan Y, Wu L, Li X, Zhao L, Xu Y Front Oncol. 2023; 13:966060.

PMID: 36969016 PMC: 10030824. DOI: 10.3389/fonc.2023.966060.


Local Delivery of Azithromycin Nanoformulation Attenuated Acute Lung Injury in Mice.

Alrashedi M, Ali A, Ahmed O, Ibrahim I Molecules. 2022; 27(23).

PMID: 36500388 PMC: 9739299. DOI: 10.3390/molecules27238293.


References
1.
Bosnar M, Kelneric Z, Munic V, Erakovic V, Parnham M . Cellular uptake and efflux of azithromycin, erythromycin, clarithromycin, telithromycin, and cethromycin. Antimicrob Agents Chemother. 2005; 49(6):2372-7. PMC: 1140530. DOI: 10.1128/AAC.49.6.2372-2377.2005. View

2.
Te Velthuis A, van den Worm S, Sims A, Baric R, Snijder E, van Hemert M . Zn(2+) inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture. PLoS Pathog. 2010; 6(11):e1001176. PMC: 2973827. DOI: 10.1371/journal.ppat.1001176. View

3.
Abrams E, Raissy H . Emerging Therapies in the Treatment of Early Childhood Wheeze. Pediatr Allergy Immunol Pulmonol. 2019; 32(2):78-80. PMC: 6733049. DOI: 10.1089/ped.2019.1043. View

4.
Ishaqui A, Khan A, Syed Sulaiman S, Alsultan M, Khan I, Naqvi A . Assessment of efficacy of Oseltamivir-Azithromycin combination therapy in prevention of Influenza-A (H1N1)pdm09 infection complications and rapidity of symptoms relief. Expert Rev Respir Med. 2020; 14(5):533-541. DOI: 10.1080/17476348.2020.1730180. View

5.
Wu Z, McGoogan J . Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13):1239-1242. DOI: 10.1001/jama.2020.2648. View